Federated Hermes
GEVA

Federated Hermes’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Federated Hermes’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-183
Closed -$18K – 2174
2015
Q1 		$18K Buy
+183
New +$19.4K ﹤0.01% 1737

Federated Hermes's GEVA Position: Q2 2015 in Review

Federated Hermes sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 183 shares — an estimated $18K sold.

Federated Hermes first reported a position in GEVA in Q1 2015 and held it in 1 quarter. The position peaked at $18K in Q1 2015. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Federated Hermes reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Federated Hermes sold 183 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $18K.
  • Federated Hermes first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q1 2015 and held it in 1 quarter.
  • Federated Hermes's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $18K in Q1 2015.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Federated Hermes's 13F filing for Q2 2015, filed 12 Aug 2015.